Does VALGANCICLOVIR Cause Polyomavirus-associated nephropathy? 66 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Polyomavirus-associated nephropathy have been filed in association with VALGANCICLOVIR (VALGANCICLOVIR). This represents 0.8% of all adverse event reports for VALGANCICLOVIR.
66
Reports of Polyomavirus-associated nephropathy with VALGANCICLOVIR
0.8%
of all VALGANCICLOVIR reports
2
Deaths
23
Hospitalizations
How Dangerous Is Polyomavirus-associated nephropathy From VALGANCICLOVIR?
Of the 66 reports, 2 (3.0%) resulted in death, 23 (34.8%) required hospitalization, and 1 (1.5%) were considered life-threatening.
Is Polyomavirus-associated nephropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALGANCICLOVIR. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does VALGANCICLOVIR Cause?
Off label use (1,882)
Cytomegalovirus infection (1,091)
Drug ineffective (886)
Neutropenia (809)
Leukopenia (574)
Drug resistance (524)
Cytomegalovirus viraemia (447)
Pancytopenia (434)
Cytomegalovirus infection reactivation (374)
Death (359)
What Other Drugs Cause Polyomavirus-associated nephropathy?
TACROLIMUS (1,477)
MYCOPHENOLATE MOFETIL (1,112)
PREDNISONE (666)
METHYLPREDNISOLONE (416)
PREDNISOLONE (402)
BASILIXIMAB (298)
EVEROLIMUS (247)
CYCLOSPORINE (246)
MYCOPHENOLIC ACID (238)
RITUXIMAB (236)
Which VALGANCICLOVIR Alternatives Have Lower Polyomavirus-associated nephropathy Risk?
VALGANCICLOVIR vs VALIUM
VALGANCICLOVIR vs VALPROATE
VALGANCICLOVIR vs VALPROIC ACID
VALGANCICLOVIR vs VALPROMIDE
VALGANCICLOVIR vs VALSARTAN